[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @med__twi El sordo El sordo posts on X about $mrkde, $gsk the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::2522249316/interactions)  - X Week XX -XX% - X Month XXXXX -XX% - X Months XXXXXX -XX% - X Year XXXXXX +51% ### Mentions: X [#](/creator/twitter::2522249316/posts_active)  - X Week X -XX% - X Month X no change - X Months XX -XX% - X Year XX +55% ### Followers: XXX [#](/creator/twitter::2522249316/followers)  - X Week XXX no change - X Month XXX -XXXX% - X Months XXX +9% - X Year XXX +11% ### CreatorRank: undefined [#](/creator/twitter::2522249316/influencer_rank)  ### Social Influence [#](/creator/twitter::2522249316/influence) --- **Social category influence** [stocks](/list/stocks) XX% **Social topic influence** [$mrkde](/topic/$mrkde) 50%, [$gsk](/topic/$gsk) XX% **Top accounts mentioned or mentioned by** [@jn66039675](/creator/undefined) **Top assets mentioned** [GSK plc (GSK)](/topic/$gsk) ### Top Social Posts [#](/creator/twitter::2522249316/posts) --- Top posts by engagements in the last XX hours "Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA" [X Link](https://x.com/med__twi/status/1966952678518673568) [@med__twi](/creator/x/med__twi) 2025-09-13T19:50Z XXX followers, XXX engagements "@Jn66039675 DNA damage as monotherapy documented in several models $GSK follows both approaches In theory could be arguments for combo with immunoTx or with DNA-directed drugs. However monotherapy activity always more promising IMO" [X Link](https://x.com/med__twi/status/1977683445343244659) [@med__twi](/creator/x/med__twi) 2025-10-13T10:30Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@med__twi El sordoEl sordo posts on X about $mrkde, $gsk the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.
Social category influence stocks XX%
Social topic influence $mrkde 50%, $gsk XX%
Top accounts mentioned or mentioned by @jn66039675
Top assets mentioned GSK plc (GSK)
Top posts by engagements in the last XX hours
"Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA"
X Link @med__twi 2025-09-13T19:50Z XXX followers, XXX engagements
"@Jn66039675 DNA damage as monotherapy documented in several models $GSK follows both approaches In theory could be arguments for combo with immunoTx or with DNA-directed drugs. However monotherapy activity always more promising IMO"
X Link @med__twi 2025-10-13T10:30Z XXX followers, XXX engagements
/creator/x::med__twi